Renin News and Research

RSS
Renin, also known as angiotensinogenase, is an enzyme that participates in the body's renin-angiotensin system (RAS) that mediates extracellular volume (i.e., that of the blood plasma, lymph and interstitial fluid), and arterial vasoconstriction. Thus, it regulates the body's mean arterial blood pressure.
Ancient Chinese practice lowers hypertension, may lessen risks of stroke and heart disease

Ancient Chinese practice lowers hypertension, may lessen risks of stroke and heart disease

Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

Researchers elucidate mechanism that induces skeletal muscle atrophy in patients with congestive heart failure

Scientists decipher new molecular signaling path that prompts protein degradation in muscle

Scientists decipher new molecular signaling path that prompts protein degradation in muscle

Brazilian cardiovascular researcher receives Georg Forster Research Award

Brazilian cardiovascular researcher receives Georg Forster Research Award

New review article explains link between PTSD and increased cardiovascular disease risk

New review article explains link between PTSD and increased cardiovascular disease risk

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

Adding high salt to high-fat diet prevents weight gain in mice

Adding high salt to high-fat diet prevents weight gain in mice

Aldosterone/renin ratio reliable diagnostic tool in infant primary hypoaldosteronism

Aldosterone/renin ratio reliable diagnostic tool in infant primary hypoaldosteronism

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

Mylan announces U.S. launch of Amlodipine and Valsartan Tablets

New oral drug shows promise in patients with chronic kidney disease

New oral drug shows promise in patients with chronic kidney disease

Novartis’ heart failure medicine LCZ696 granted FDA priority review

Novartis’ heart failure medicine LCZ696 granted FDA priority review

Novartis receives priority review status from FDA for heart failure medicine LCZ696

Novartis receives priority review status from FDA for heart failure medicine LCZ696

President of Institute of Medicine to deliver presentation at University of Louisville

President of Institute of Medicine to deliver presentation at University of Louisville

Investigational drug maintains normal potassium levels in patients with chronic kidney disease

Investigational drug maintains normal potassium levels in patients with chronic kidney disease

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Inadequate management common in young-onset Type 2 diabetes

Inadequate management common in young-onset Type 2 diabetes

New path may lead to powerful adjunctive novel therapy for PTSD treatment

New path may lead to powerful adjunctive novel therapy for PTSD treatment

Endocrine Society announces winners of Early Investigators Awards and FLARE Internship Awards

Endocrine Society announces winners of Early Investigators Awards and FLARE Internship Awards

Forest publishes data from pivotal Phase III Study of Investigational FDC of nebivolol and valsartan

Forest publishes data from pivotal Phase III Study of Investigational FDC of nebivolol and valsartan

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit